OUR RECOMMENDATION
| CMP# | 731.1 |
| Idea | BUY |
| Buy Range | 720 – 730 |
| Target | 790 – 814 |
| StopLoss* | 700 |
| Duration | 25 – 30 Trading Sessions |
| Potential Return^ | 8 – 11% |
| CMP# | Idea | Buy Range | Target | StopLoss* | Duration | Potential Return^ |
| 731.1 | BUY | 720 – 730 | 790 – 814 | 700 | 25 – 30 Trading Sessions | 8 – 11% |
# CMP on Feb 21, 2019
* Maintain recommended StopLoss by daily closing basis.
Once 1st target hit, reset StopLoss at 761.
^ The returns are calculated based on CMP#
COMPANY OVERVIEW
Incorporated in 26th December 1986, this generic drug manufacturing company is developing, manufacturing and marketing 7 major product areas encompassing Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterological, Anti-Allergics and Anti-Diabetics. The vast majority of the company’s sales are generated in India, followed by the United States and globally in over 150 countries.
| Stock Data | |
| NSE Code | AUROPHARMA |
| Sectoral Index | Nifty Pharma |
| 52W High | 816 |
| 52W Low | 527 |
| Face Value | 1 |
TECHNICAL OBSERVATIONS (WEEKLY)
- The stock price has been moving in a narrow consolidated range in the last five months and the recent price has placed near the lower end of a sideways range.
- Based on the historical price pattern, we may expect price to move up from here.
TECHNICAL OBSERVATIONS (DAILY)
- The stock had formed Bullish Engulfing candlestick near the bottom which is a bullish reversal formation. Normally this type of candlestick suggests the bull has taken control of a security’s price movement from bears.
- CCI(14) has given the buy signal. This happens when the CCI dips below -100 and then rallies back above -100.
